In addition, when compared with the T2DM group, the patients with HCC or T2DM & HCC also had higher γGT, TBA, AFP, and FGF19 concentrations (all p < 0.05) (Figures 1 and 2). This evidence concerns the gene FGF19 and hepatocellular carcinoma.